203 related articles for article (PubMed ID: 16476928)
21. A national survey of acute cerebrovascular disease in Israel: burden, management, outcome and adherence to guidelines.
Tanne D; Goldbourt U; Koton S; Grossman E; Koren-Morag N; Green MS; Bornstein NM;
Isr Med Assoc J; 2006 Jan; 8(1):3-7. PubMed ID: 16450742
[TBL] [Abstract][Full Text] [Related]
22. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
23. Characterization of ischemic events and use of prescription antiplatelet and anticoagulant agents after stroke or transient ischemic attack.
Zaher C; Schloss S; George D; Poret AW; Shah H
J Stroke Cerebrovasc Dis; 2005; 14(4):145-51. PubMed ID: 17904016
[TBL] [Abstract][Full Text] [Related]
24. The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke.
Po HL; Lin YJ; Hseuh IH
Acta Neurol Taiwan; 2009 Jun; 18(2):98-103. PubMed ID: 19673361
[TBL] [Abstract][Full Text] [Related]
25. Use of secondary preventive medications after the first attack of acute coronary syndrome.
Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
[TBL] [Abstract][Full Text] [Related]
26. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of antihypertensive therapy among ischemic stroke survivors: impact of ischemic heart disease.
Hassan Y; Aziz NA; Al-Jabi SW; Looi I; Zyoud SH
J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):282-8. PubMed ID: 20472813
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event.
Ovbiagele B; Hills NK; Saver JL; Johnston SC
Stroke; 2005 Sep; 36(9):1944-7. PubMed ID: 16051895
[TBL] [Abstract][Full Text] [Related]
29. Tracking trends in secondary stroke prevention strategies.
Carswell JL; Beard KA; Chevrette MM; Pardue CN; Hess DC; Fagan SC
Ann Pharmacother; 2004 Feb; 38(2):215-9. PubMed ID: 14742753
[TBL] [Abstract][Full Text] [Related]
30. The emergency department: first line of defense in preventing secondary stroke.
Ovbiagele B
Acad Emerg Med; 2006 Feb; 13(2):215-22. PubMed ID: 16436789
[TBL] [Abstract][Full Text] [Related]
31. Aspirin non-responders in Thai ischemic stroke/TIA patients.
Dharmasaroja P
J Med Assoc Thai; 2008 Jun; 91(6):818-21. PubMed ID: 18697379
[TBL] [Abstract][Full Text] [Related]
32. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
[TBL] [Abstract][Full Text] [Related]
33. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
Dowlatshahi D; Hakim A; Fang J; Sharma M;
Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119
[TBL] [Abstract][Full Text] [Related]
34. Stroke and TIA: epidemiology, risk factors, and the need for early intervention.
Fisher M
Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S204-11. PubMed ID: 18611102
[TBL] [Abstract][Full Text] [Related]
35. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
[TBL] [Abstract][Full Text] [Related]
36. [Transient ischemic attack, a medical emergency].
Uchiyama S
Brain Nerve; 2009 Sep; 61(9):1013-22. PubMed ID: 19803400
[TBL] [Abstract][Full Text] [Related]
37. Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study.
Dahlgren C; Geary L; Hasselström J; Rehnberg C; Schenck-Gustafsson K; Wändell P; Euler MV
BMJ Open; 2017 Sep; 7(9):e015723. PubMed ID: 28939569
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
[TBL] [Abstract][Full Text] [Related]
39. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
40. Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006.
Fonarow GC; French WJ; Frederick PD
Am Heart J; 2009 Jan; 157(1):185-194.e2. PubMed ID: 19081417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
